Power3 Hires Middle East Distributor for Proteomic-Based Breast Cancer Dx

Oct 16, 2007

NEW YORK (GenomeWeb News) — Power3 Medical Products said yesterday it has hired Bahrain-based Financial Advisory House to market and distribute a proteomics-based breast cancer test in 12 countries in the Middle East.

Under the agreement, FAH’s Medical Equipment Suppliers division will market and distribute Power3’s BC-SeraPro breast cancer diagnostic in Bahrain; Egypt; Iraq; Jordan; Kuwait; Lebanon; Saudi Arabia; Oman; Qatar; Syria; the United Arab Emirates; and Yemen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu